Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

CYTOO’s 2D+ Technology and Institut Curie’s Organelle Map in the limelight at SLAS 2013

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
CYTOO will attend the Society for Laboratory Automation and Screening (SLAS) 2013 conference on 12-16 Jan, in Orlando, Florida, USA.

The company will present their 2D+ Solutions, opening fresh perspectives for cell based assay development in drug discovery.

2D+ Solutions are based on CYTOO’s standard and custom adhesive micropatterns in 96-well plates which guide cell architecture and behavior. By defining the 2D topology of cell adhesion, the 2D+ Cell Culture Platform enables fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations. This approach results in control of cell contractility, cell polarity, organelle positioning, and cell division axis.

2D+ Custom Solutions are specifically designed to bring expertise, resources and technology to address current bottlenecks in cell based assay development and screening in drug discovery.

2D+ Custom Solutions include: Exploratory solutions to guide customers through the initial exploration of the 2D+ technology with experienced PhD-level expert support; Assay development to select the best ecosystem for the requested cells; Screening to run pilot or full sized screens. All Solutions are tailored to the customer’s needs and can be carried out in the customer’s facilities or outsourced to CYTOO, on our fully equipped HCS screening platform.

The 2D+ technology addresses a major concern with traditional 2D culture, in which cells spread and move in an uncontrolled manner, introducing a considerable but unnoticed variability in cell function. Kristine Schauer, from the Institut Curie in Paris, France, used the crossbow adhesive micropatterns to get reproducible shape and distribution of intracellular compartments and developed a mathematical algorithm to generate and compare probabilistic density maps of the different endosome compartments.

This innovative approach is a powerful universal method to identify statistically relevant hits and drug effects in complex cell based assays, and according to Michel Bornens, COO at CYTOO “the method has now the potential to become a gold-standard in the quantitative analysis of cell-based high-throughput data”. Kristine Schauer’s Organelle Map figures among the nine 2013 SLAS Innovation Award finalists. A $10,000 cash prize will be attributed during SLAS 2013, and recognizes extraordinary achievement in innovative laboratory science and technology.

Attendees are invited to visit booth #310 to discuss their application with François Chatelain, President and CEO, and Lisa Minor, Application Development Leader.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos